CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

All Therapeutic Areas
🎗️

Oncology

255 drugs in pipeline from 10 companies

255

Drugs in Pipeline

10

Companies

10

Upcoming Catalysts

255

Phase 3 Trials

Upcoming Catalysts
Jul '26
INCYPhase 2

INCB177054 Phase 2 Est. Readout

INCB177054
Jul 2026~STALE+IMMINENT
CT.gov
00%
Jul '26
JNGHFPhase 3

TACE+Camrelizumab+Apatinib mesylate Phase 3 Est. Readout

TACE+Camrelizumab+Apatinib mesylate
Jul 2026~
CT.gov
00%
Jul '26
JNGHFPhase 2

JSKN003 Phase 2 Est. Readout

JSKN003
Jul 2026~STALE+IMMINENT
CT.gov
00%
Jul '26
JAZZPhase 3

Tislelizumab Phase 3 Est. Readout

Capecitabine
Jul 2026~STALE+IMMINENT
CT.gov
00%
Jul '26
HNSPFPhase 2

HS-20093 Phase 2 Est. Readout

HS-20093
Jul 2026~
CT.gov
00%
2d
days
ZLABPDUFA
Phase 3?Unknown

FDA PDUFA Date Elzovantinib (priority)

Investigator's Choice of Therapy
Jul 31
SEC
Jul '26
MRKPhase 3
Negative

Pembrolizumab Phase 3 Est. Readout

pembrolizumab
Jul 2026~
CT.gov
2d
days
MRKPhase 3
Positive

BCG Phase 3 Results Expected

BCG
Jul 31
CT.gov
Jul '26
ORNBV.HEPhase 2

ODM-208 Phase 2 Est. Readout

ODM-208
Jul 2026~
CT.gov
00%
Jul '26
JNGHFPhase 3

Rivoceranib (Apatinib) Phase 3 Est. Readout

Rivoceranib (Apatinib)
Jul 2026~
CT.gov
00%
Pipeline by Phase
Phase 3
255
Related Conditions
cancertumorcarcinomalymphomaleukemiamelanomaoncologysarcomamyelomametastaticneoplasmmalignantbreast cancerlung cancerprostate cancercolorectalpancreaticglioblastomahepatocellularrenal cellovarianbladdernsclcsclcamlcllalldlbclhodgkinnon-hodgkin